Abstract -Hormonal steroids, such as 17 -estradio1 derivatives, labelled with organometallic moieties have been synthesized and tested as markers for hormone receptor assay. Among the organometallic labels used were : Cr(C0) and Cr(C0)9(CS) which5can be attached to the arene A ring of the sterid ; Co9(C06 and Mo(rì -CH)9(C0)4 which can be bonded to acetylenic groups introduced at the 17c-p6sWton o the flve'-membered steroidal ring. There is a spectral window at about 2000 cm' in the FT-IR spectra of the protein precipitated from lamb uterus cytosol which we reasoned could be used to detect the v(C0) modes of the metal carbonyl fragments of the organometallic labels. This indeed proved possible and the present detection level for 10,000-20,000 co-added scans at 4cm1 resolution is in the neighborhood of 100 fM. That specific rather than non-specific receptor sites were being detected was demonstrated by preparing an estradiol derivative doubly labelled with tritium and Cr(C0)3 and comparable receptor-site concentration levels were measured by both radiochemical analysis and FI-IR spectroscopy. The potential application of this new receptor assay technique in the early diagnosis of hormonedependent cancers appears feasible.
INTRODUCTION
Although the utility of transition metal carbonyl complexes in organic synthesis and industrial catalysis is now well established, their potential in biochemistry is only just being realized (ref. 1). Particularly, the biochemical importance of steroidal hormones which have been modified by the incorporation of organometallic moieties has only recently been appreciated (ref. 2) . These species indeed show promise of unprecedented applications in the field of molecular biology in that they can function as markers in the study of receptors (ref. 2) , are useful in immunology (ref. 3) and also serve as synthetic intermediates in regio -and stereospecific functionalisations (ref. 4 ). This promise is founded firstly on the ability of derivatives of hormones to recognize their specific receptor, and secondly on the strong absorptions of the metal carbonyl moieties in the infrared region 2100-1850 cm' ; this frequency range is compatible with a window in which the proteins do not absorb. This concept opens new vistas (e.g. an unprecedented use of such organometallic complexes in the field of steroid hormone receptor assay) whose full potential can hardly be ascertained at present. We note that this extension beyond the normal realm of transition metal complexes and into bio-organometallic chemistry has only become viable with the advent of Fourier Transform infrared techniques (FT-IR) which lowers the threshold of detection of so labelled hormones to the level of a few femtomoles per milligram of protein (ref. 2) . This concentration corresponds to that commonly encountered in biological systems and so could be used to monitor the hormone dependance of breast cancer, Nevertheless, in spite of this enormous potential, there are still very few studies reported on these steroid complexes (ref. 5 ).
MODEL OF STEROID HORMONE ACTION
The steroids are a group of naturally occurring organic compounds and their synthetic derivatives, all of which are characterized by a basic skeleton consisting of three sixmembered rings and one five-membered ring (scheme 1). The intimate involvement of steroids in the cause of certain cancers (such as breast cancers) is now well established (ref. 6 ).
Until 1984, there was general agreement that the following sequence of events takes place when steroidal hormones, such as oestrogens ( scheme 2), come in contact wjth a target cell oestrogen enters the cell and interaclswith specific receptor proteins in the cytoplasm, forming non covalent, high affinity complexes ; the complex undergoes some change (activation) and translocates to the nucleus ; it then interacts with nuclear In order to establish unequivocally the structure of one complex it was found that the most satisfactory crystals were those of the thiocarbonyl complex 12; X-ray crystallographic determination of the structure revealed that the thiocarbonyldTcarbonylchromium trippd is attached to the c face of the steroid as depicted in scheme 6. Having stab1ished the absolute configurations of the molecules 2 through 15, one can now examine the analytical methods available which, in principle, miht be useto provide a relatively simple yet definitive means of differentiating between a-and 3-comDlexes. At first sight, one might have visualized that the -complexed molecules should be sterically disfavored because of non-bonded interactions between the tripod and the methyl group at C-13 ; indeed, the behaviour of the Cr(CO)3 complexes of the methylindanes supports this idea (ref. 18 ). However, the relative yields of a-to s-isomers do not reflect the supposed importance of this steric effect. Thus, the experimental data (56 ; 44 for 4 : 5 and 41 : 59 for 10 : i) reveal that the proportions of the diastereomers are inverted henThne pises from one series to the other. Clearly, one cannot use such a criterion in these cases since it is difficult to know whether the reaction is thermodynamically or kinetically controlled. Furthermore, the incorporation of substituents which may interact competitively makes prediction difficult. Thus, 1-methylindane leads preferentially to the exo isomer (presumably for steric reasons), in contrast, 1-indanol yields exclusiv137 the endo configuration (ref. 14) (ref. 18 ). In oestradiol, however, these same two substT€üints are positioned contiguously on the face and the relative importance of these opposing effects is unpredictable.
Similarly, the specific rotation and the Rf values, as well as the infrared stretching frequencies of the carbonyl functionalities,do not permit accurate determination of the absolute configurations of these pairs of diastereomers.
However, an examination of the high resolution 'H NMR spectrum of the Cr(CO)3 complexes of oestradiol and its derivatives allows ready differentiation of the a-and s-isomers. The 500 MHz 1H spectra of the a-and -complexes, 6 and 7, are presented in figure 1.
Again, peak overlap is a problem and has to be overcome vTa a 2-D NMR experiment. In the infrared spectra of all proteins there is a spectral window at 2000cm and it occurred to us that the introduction of metal carbonyls as probe molecules might be a convenient way of monitoring certain biochemical processes since these compounds have extremely intense (C0) peaks in the 2150-1800 cm-1 region (ref. 23 ).
In principle, this simple concept may be of wide applicability. To illustrate our organometallic labelling/infrared spectroscopy approach, we have applied it to oestradiol receptor (E2R) for which the current methods of assaying utilize radiolabelled hormones
The first requirement to be met in the preparation of labelled hormones is,that the compounds be stable in solution and that they retain a high specificity for recognition of the relevant receptor. The preseqt, highly-developed state of transition organometallic chemistry offers the opportunity to synthesize and exploit a rich and versatile new class of tailor-made metal carbonyl oestrogens. As shown before, an obvious site for complexation of oestradiol derivatives is the aromatic ring and the organometallic unit most compatible with such a six-electron ligand is the Cr(C0)3 moiety (ref. 14). Oestradiol derivatives without modification of the phenol function are unsuitable for our purpose snce, after fixation of the Cr(C0)3 unit, these phenolic complexes rapidly decompose in solution giving rise to the free ligand and chromium salts. However, a modification of the 3-hydroxy function of the hormone results in complexes that are stable for years in the solid state and for several days in solution in the dark (scheme 7).
The binding affinities of the modified oestrogen complexes were determined by a competitive binding assay using tritium-labelled oestradiol as a tracer and lamb uterine cytosol as a source of oestradiol receptor. The relative binding affinity (RBA) of the competitors is taken as the ratio of the concentrations of unlabelled competitors required to inhibit half of the specific (3H)-oestradiol binding with the affinity of oestradiol set at 100%. Receptor Binding Affinity of synthetized oestradiol derivatives. bValues by definition.
In addition to having sufficient stability in solution, the modified oestrogen complexes were found to be effective in the competitive inhibition test, suggesting a favorable binding to the oestradiol receptor. However, a good affinity is regained when the 3-hydroxyl function is maintained away from the steroid skeleton by a spacer chain (-0-(CH2)3-) 17. It appears also that the fixation site of the tripod on the A ring of the steroid stroly discriminates the ct and diastereomers with respect to their recognition properties, While the s-isomers (11, 19) show relatively modest affinities, the ct-isomers (10, 12, 18) ;IIIIIyI With labelled oestrogens used to measure the oestrogen receptor content of breast tumor samples, non-receptor binding can reduce the sensitivity of the assay procedure. In order to prove the specific association of the chromium-labelled steroids for the oestradiol receptor site, we prepared compound 18 tritium labelled at the l7ct-position (scheme 9)and performed in vitro incubation experiints (Table 2) . In this way, we were able to demonstrate that the radioactive hormone is bound specifically and reversibly to the uterine oestrogen receptor. Furthermore, the amount of nonspecific binding is only slightly increased when compared to that of (3H)-oestradiol itself. We also checked that compound 18, as well as oestradiol, binds poorly to, and is not displaced by D.E.S. from high-.ipacity, low-affinity proteins found in non-target tissues (e.g.rat lung). Based on the RBA values, most of the complexes listed in Table 1 should be useful for a receptor assay. The FT-IR spectrum of a lamb uterine cytosol incubated with oestradiol and precipitated by protamine sulfate shows a window just below 2,000cmi( Fig.2 and 3) . In natural proteins, this situation is very general. The FT-IR spectrum of compound 18 is given in Fig. 4 ; the two v(C0) peaks characteristic of the C symmetry Cr(CO) fragment are the strongest absorptions present. Similarly, th organometallic ostradiol -1 derivative 10 exhibIts the two (C0) modes of vibration of the Cr(C0)3 moiety at 1959.6cm (Al) and 1876.4 cm (E) (Fig. 5) . Next, in Fig.6 , we show the FT-IR spectrum of the precipitated proteins following incubation with the organometallic tritiated compound 18 at approximately the same concentration (cl0 M) as currently used in the radiochemicT assays using oestradiol itself. The protein absorptions are off-scale owing to the thickness of the minipellet but two very weak features can be discerned above the backgroung at l900cm1. The computer expansion of this region shown in Fig.7 reveals the two v(C0) peaks of the organometallic marker. Similar results were obtained withall the chromium tricarbonyl labelled oestradiol molecules synthesized in this work ; the example of 10 is depicted in Fig. 8 . While the best signal-to-noise conditions for the spectra necessitated recording 10,000-30,000 scans at 4 cm4 resolution (3-lOh), the two metal carbonyl peaks can just be detected above the background at 8cm1 resolution in 2 mm. These examples contain about 300 femtomoles of oestradiol receptor per mg of protein, This set of experiments establishes the feasability of a highly sensitive metal carbonyl oestrogen receptor assay.
In order to illustrate the effect of changing the point group symmetry of the organometallic label (Cs instead of C in 10 and 18) the final spectrum obtained for 12 is shown in Fig. 9 . Two peaks are servid at llcm1 (A') and l884cm1 (A"). The lifts in the v(C0) peaks compared to the tricarbonyl derivati've provide further evidence of complexation of the organometallic label to the receptor site.
There is an excellent correlation (R = 0.98) between the area of the higher-energy v(C0) peak in the experiments with compound 18 and the weight of the minipellets (1-2mg) indicating that in principle it shoulde possible to extend this new method of protein receptor detection into the quantitative realm in the future (Fig. 10) . The organometallic labelling is not, of course, limitated to the fixation of Cr(C0) units onto arene rings. For example, the possibility of modifying the l7c position of oesradiol by adding small clusters is depicted on scheme 12. These complexes 22 and 23 are stable in solution and show reasonable RBA vTues (12-14%). Therifore, ital carbonyl clusters can also be envisaged as markers in biochemistry.
These results lead to the following conclusions the detection limit of FT-IR appears to be as low as 1012g of metallic markers per mq of protein.This sensitivity satisfies the requirements for a receptor assay in contrast with other existing analytical methods for the detection of organometallic units such as atomic absorption or electrochemical techniques, for which the detection limits do not exceed 106g.ll and 10'7g.l1 respectively. Moreover, the reasonably good specific binding properties obtained for our organometallic oestrogens differ strongly from the behaviour of synthetic fluorescent hormones which suffer from a high level of non specific binding. In addition to the above characteristics, the following advantages could also make metal carbonyl markers a useful alternative to radioactive molecules in biological systems a) ease of preparation, b) low cost, c) long-term stability of the complexes, d) rapidity of the measurements (2-3 hr), e) predictable shape and positions of the v(C0) signals (no artefact possible), f) compatibility with radio isotopic labelling agents (double labelling problems). Furthermore, the initial high costs associated with the purchase of an FT-IR spectrometer have decreased rapidly over the past few years, The best obtainable complex in this series has been, so far, complex 21 for which a 2% BA value was measured. According to Katzenellenbogen (ref. 27 ) compoüids for which the affinity lies in the 0.5-5% range might be useful for labelling semipurified preparations of proteins and thus compound 27 could be a marker for oestradiol receptor detection. C.
Cr(CO)3
Scheme 12.
CONCLUSION
